Matches in DBpedia 2016-04 for { <http://dbpedia.org/resource/Tipifarnib> ?p ?o }
Showing triples 1 to 65 of
65
with 100 triples per page.
- Tipifarnib abstract "Tipifarnib (trade name Zarnestra) is a farnesyltransferase inhibitor that is being investigated in patients 65 years of age and older with newly diagnosed acute myeloid leukemia (AML). It inhibits the Ras kinase in a post translational modification step before the kinase pathway becomes hyperactive. It inhibits prenylation of the CxxX tail motif, which allows Ras to bind to the membrane where it is active. Without this step the protein cannot function.It is also being tested in clinical trials in patients in certain stages of breast cancer.For treatment of progressive plexiform neurofibromas associated with Neurofibromatosis type I, it successfully passed phase one clinical trials but was suspended (NCT00029354) in phase two.The compound was discovered by and is under investigation by Johnson & Johnson Pharmaceutical Research & Development, L.L.C, with registration number R115777.".
- Tipifarnib atcPrefix "none".
- Tipifarnib fdaUniiCode "MAT637500A".
- Tipifarnib iupacName "6-[amino(4-chlorophenyl)(1-methyl-1H-imidazol-5-yl)methyl]-4-(3-chlorophenyl)-1-methylquinolin-2(1H)-one".
- Tipifarnib pubchem "148193".
- Tipifarnib thumbnail Tipifarnib.png?width=300.
- Tipifarnib wikiPageID "6806262".
- Tipifarnib wikiPageLength "3692".
- Tipifarnib wikiPageOutDegree "9".
- Tipifarnib wikiPageRevisionID "644864783".
- Tipifarnib wikiPageWikiLink Acute_myeloid_leukemia.
- Tipifarnib wikiPageWikiLink Category:Farnesyltransferase_inhibitors.
- Tipifarnib wikiPageWikiLink Category:Imidazoles.
- Tipifarnib wikiPageWikiLink Farnesyltransferase_inhibitor.
- Tipifarnib wikiPageWikiLink Johnson_&_Johnson.
- Tipifarnib wikiPageWikiLink Johnson_&_Johnson_Pharmaceutical_Research_and_Development.
- Tipifarnib wikiPageWikiLink Neurofibroma.
- Tipifarnib wikiPageWikiLink Neurofibromatosis_type_I.
- Tipifarnib wikiPageWikiLink File:Progeria20132-300.jpg.
- Tipifarnib wikiPageWikiLinkText "Tipifarnib".
- Tipifarnib wikiPageWikiLinkText "tipifarnib".
- Tipifarnib atcPrefix "none".
- Tipifarnib c "27".
- Tipifarnib chembl "289228".
- Tipifarnib cl "2".
- Tipifarnib h "22".
- Tipifarnib iupacName "6".
- Tipifarnib molecularWeight "489.395".
- Tipifarnib n "4".
- Tipifarnib o "1".
- Tipifarnib pubchem "148193".
- Tipifarnib unii "MAT637500A".
- Tipifarnib verifiedfields "changed".
- Tipifarnib verifiedrevid "376279232".
- Tipifarnib wikiPageUsesTemplate Template:Antineoplastic-drug-stub.
- Tipifarnib wikiPageUsesTemplate Template:Cascite.
- Tipifarnib wikiPageUsesTemplate Template:Chemotherapeutic_agents.
- Tipifarnib wikiPageUsesTemplate Template:Drugbankcite.
- Tipifarnib wikiPageUsesTemplate Template:Drugbox.
- Tipifarnib wikiPageUsesTemplate Template:Ebicite.
- Tipifarnib wikiPageUsesTemplate Template:Fdacite.
- Tipifarnib wikiPageUsesTemplate Template:Reflist.
- Tipifarnib subject Category:Farnesyltransferase_inhibitors.
- Tipifarnib subject Category:Imidazoles.
- Tipifarnib hypernym Inhibitor.
- Tipifarnib type ChemicalSubstance.
- Tipifarnib type Drug.
- Tipifarnib type Brand.
- Tipifarnib type Chemical.
- Tipifarnib type Diazole.
- Tipifarnib type Drug.
- Tipifarnib type Inhibitor.
- Tipifarnib type ChemicalObject.
- Tipifarnib type Thing.
- Tipifarnib type Q8386.
- Tipifarnib comment "Tipifarnib (trade name Zarnestra) is a farnesyltransferase inhibitor that is being investigated in patients 65 years of age and older with newly diagnosed acute myeloid leukemia (AML). It inhibits the Ras kinase in a post translational modification step before the kinase pathway becomes hyperactive. It inhibits prenylation of the CxxX tail motif, which allows Ras to bind to the membrane where it is active.".
- Tipifarnib label "Tipifarnib".
- Tipifarnib sameAs Q7808830.
- Tipifarnib sameAs m.0gpw9k.
- Tipifarnib sameAs Tipifarnib.
- Tipifarnib sameAs Tipifarnib.
- Tipifarnib sameAs Q7808830.
- Tipifarnib wasDerivedFrom Tipifarnib?oldid=644864783.
- Tipifarnib depiction Tipifarnib.png.
- Tipifarnib isPrimaryTopicOf Tipifarnib.